Copd - Revision history

Richardpruen: /* Studies/papers */ Tidy and add bullet points

2024-03-09T17:06:35Z

Studies/papers: Tidy and add bullet points

← Older revision		Revision as of 18:06, 9 March 2024
Line 54:		Line 54:

	== Studies/papers ==		== Studies/papers ==
	2023: [https://www.tandfonline.com/doi/full/10.1080/17476348.2023.2167716 Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: Current and emerging evidence] '''Morjaria JB, Campagna D, Caci G, O'Leary R, Polosa R. doi: 10.1080/17476348.2023.2167716. Epub ahead of print. PMID: 36638185.'''

			=== 2023: [https://www.tandfonline.com/doi/full/10.1080/17476348.2023.2167716 Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: Current and emerging evidence] '''Morjaria JB, Campagna D, Caci G, O'Leary R, Polosa R. doi: 10.1080/17476348.2023.2167716. Epub ahead of print. PMID: 36638185.''' ===
	* Compared with conventional cigarettes, HTPs and ECs offer substantial reduction in exposure to toxic chemicals and have the potential to reduce harm from cigarette smoke when used as tobacco cigarette substitutes. In this review, we examine the available clinical studies and population surveys on the respiratory health effects of ECs and HTPs in COPD patients.		* Compared with conventional cigarettes, HTPs and ECs offer substantial reduction in exposure to toxic chemicals and have the potential to reduce harm from cigarette smoke when used as tobacco cigarette substitutes. In this review, we examine the available clinical studies and population surveys on the respiratory health effects of ECs and HTPs in COPD patients.
	* As many COPD smokers prefer to smoke, conventional cigarette substitution should be considered as a valuable solution to the persistent problem of smoking, and combustion-free nicotine delivery technologies should be weight as a component of this strategy.		* As many COPD smokers prefer to smoke, conventional cigarette substitution should be considered as a valuable solution to the persistent problem of smoking, and combustion-free nicotine delivery technologies should be weight as a component of this strategy.
Line 61:		Line 61:
	* This review article highlights the need for large, carefully designed, adequately controlled, long- term follow-up clinical trials to assess the true potential of combustion-free nicotine delivery technologies for sustained smoking cessation and reducing risk of harm from smoking, particularly among smokers with chronic obstructive pulmonary disease (COPD).		* This review article highlights the need for large, carefully designed, adequately controlled, long- term follow-up clinical trials to assess the true potential of combustion-free nicotine delivery technologies for sustained smoking cessation and reducing risk of harm from smoking, particularly among smokers with chronic obstructive pulmonary disease (COPD).

	2020: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549158/ COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up]		=== 2020: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549158/ COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up] ===

	~~2021: [https://link~~.~~springer~~.~~com/article/10~~.~~1007/s11739~~-~~021-02674-3 Health outcomes~~ in ~~COPD smokers using heated tobacco products: a 3~~-year ~~follow-up]~~		* Those in the EC user group achieved a marked decline in cigarette smoking or abstinence. COPD EC users had a significant diminution in COPD exacerbations; with the mean (±SD) exacerbation rate falling from 2.3 (±0.9) at baseline to 1.1 (±1.0) at 5 years (''p'' < 0.001), whereas no significant changes were observed in the control group.
			* Patients were evaluated prospectively for their measurements of respiratory exacerbations, spirometric indices, quality of life using the COPD assessment tool (CAT), 6-min walk distance (6MWD), as well as conventional cigarette consumption.
			* Significant and constant improvements in lung function, CAT scores and 6MWD were reported in the EC user group over the 5-year observation period compared with the reference group (''p'' < 0.05).

	~~2022~~: [https://~~ascpjournal~~.~~biomedcentral~~.com/~~articles~~/10.~~1186~~/~~s13722~~-021-~~00284~~-~~0 Electronic cigarettes as a harm reduction strategy among patients with~~ COPD: ~~protocol for an open~~-~~label two arm randomized controlled pilot trial~~]		=== 2021: [https://link.springer.com/article/10.1007/s11739-021-02674-3 Health outcomes in COPD smokers using heated tobacco products: a 3-year follow-up] ===

			=== 2022: [https://ascpjournal.biomedcentral.com/articles/10.1186/s13722-021-00284-0 Electronic cigarettes as a harm reduction strategy among patients with COPD: protocol for an open-label two arm randomized controlled pilot trial] ===
	* A harm reduction approach with the goal of achieving CC switching may be a more pragmatic approach, making EC use particularly appropriate with COPD [25]. EC represent a potentially effective harm reduction tool that is safer than smoking CC [18, 23, 24]. Smokers with COPD, however, tend to be older and may have a higher level of addiction to nicotine than the average smoker and the feasibility and preliminary effectiveness of an EC harm-reduction strategy in a COPD population has not been explored.		* A harm reduction approach with the goal of achieving CC switching may be a more pragmatic approach, making EC use particularly appropriate with COPD [25]. EC represent a potentially effective harm reduction tool that is safer than smoking CC [18, 23, 24]. Smokers with COPD, however, tend to be older and may have a higher level of addiction to nicotine than the average smoker and the feasibility and preliminary effectiveness of an EC harm-reduction strategy in a COPD population has not been explored.
	* Our study protocol has a few limitations. First, as a pilot study the protocol is not powered to detect small differences in CPD or CAT Scores between the NRT and EC arms. Second, CAT Score is not the gold standard for the assessment of respiratory health.		* Our study protocol has a few limitations. First, as a pilot study the protocol is not powered to detect small differences in CPD or CAT Scores between the NRT and EC arms. Second, CAT Score is not the gold standard for the assessment of respiratory health.

Richardpruen: /* Studies/papers */ added latest info

2023-01-14T14:14:37Z

Studies/papers: added latest info

← Older revision		Revision as of 15:14, 14 January 2023
Line 54:		Line 54:

	== Studies/papers ==		== Studies/papers ==
			2023: [https://www.tandfonline.com/doi/full/10.1080/17476348.2023.2167716 Health impact of e-cigarettes and heated tobacco products in chronic obstructive pulmonary disease: Current and emerging evidence] '''Morjaria JB, Campagna D, Caci G, O'Leary R, Polosa R. doi: 10.1080/17476348.2023.2167716. Epub ahead of print. PMID: 36638185.'''

			* Compared with conventional cigarettes, HTPs and ECs offer substantial reduction in exposure to toxic chemicals and have the potential to reduce harm from cigarette smoke when used as tobacco cigarette substitutes. In this review, we examine the available clinical studies and population surveys on the respiratory health effects of ECs and HTPs in COPD patients.
			* As many COPD smokers prefer to smoke, conventional cigarette substitution should be considered as a valuable solution to the persistent problem of smoking, and combustion-free nicotine delivery technologies should be weight as a component of this strategy.
			* Our analysis of existing human studies on the respiratory health impact of ECs/HTPs substitution for COPD patients who smoke, fails to reach a clear conclusion because of the discordant findings and unreliable interpretations driven from surveys and clinical studies of modest quality.
			* This review article highlights the need for large, carefully designed, adequately controlled, long- term follow-up clinical trials to assess the true potential of combustion-free nicotine delivery technologies for sustained smoking cessation and reducing risk of harm from smoking, particularly among smokers with chronic obstructive pulmonary disease (COPD).

	2020: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549158/ COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up]		2020: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549158/ COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up]

Richardpruen: /* Studies/papers */ added more detail

2022-12-07T13:17:51Z

Studies/papers: added more detail

← Older revision		Revision as of 14:17, 7 December 2022
Line 42:		Line 42:

	=What are the symptoms of COPD?=		=What are the symptoms of COPD?=


	Symptoms include:		Symptoms include:
Line 51:		Line 50:

	You might get these symptoms all the time, or they might appear or get worse when you have an infection or breathe in smoke or fumes.		You might get these symptoms all the time, or they might appear or get worse when you have an infection or breathe in smoke or fumes.


	If you have COPD that has a severe impact on your breathing, you can lose your appetite, lose weight and find that your ankles swell.		If you have COPD that has a severe impact on your breathing, you can lose your appetite, lose weight and find that your ankles swell.

	== Studies/papers ==		== Studies/papers ==
	[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549158/ COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up]		2020: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549158/ COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up]

			2021: [https://link.springer.com/article/10.1007/s11739-021-02674-3 Health outcomes in COPD smokers using heated tobacco products: a 3-year follow-up]

			2022: [https://ascpjournal.biomedcentral.com/articles/10.1186/s13722-021-00284-0 Electronic cigarettes as a harm reduction strategy among patients with COPD: protocol for an open-label two arm randomized controlled pilot trial]

	[~~https://link~~.~~springer~~.~~com/article/10.1007/s11739~~-~~021-02674-3 2021: Health outcomes~~ in COPD ~~smokers using heated tobacco products:~~ a ~~3-year follow-up]~~		* A harm reduction approach with the goal of achieving CC switching may be a more pragmatic approach, making EC use particularly appropriate with COPD [25]. EC represent a potentially effective harm reduction tool that is safer than smoking CC [18, 23, 24]. Smokers with COPD, however, tend to be older and may have a higher level of addiction to nicotine than the average smoker and the feasibility and preliminary effectiveness of an EC harm-reduction strategy in a COPD population has not been explored.
			* Our study protocol has a few limitations. First, as a pilot study the protocol is not powered to detect small differences in CPD or CAT Scores between the NRT and EC arms. Second, CAT Score is not the gold standard for the assessment of respiratory health.

	=External Links=		=External Links=

Richardpruen: added studies

2022-12-07T12:27:28Z

added studies

← Older revision		Revision as of 13:27, 7 December 2022
Line 54:		Line 54:

	If you have COPD that has a severe impact on your breathing, you can lose your appetite, lose weight and find that your ankles swell.		If you have COPD that has a severe impact on your breathing, you can lose your appetite, lose weight and find that your ankles swell.

			== Studies/papers ==
			[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549158/ COPD smokers who switched to e-cigarettes: health outcomes at 5-year follow up]

			[https://link.springer.com/article/10.1007/s11739-021-02674-3 2021: Health outcomes in COPD smokers using heated tobacco products: a 3-year follow-up]

	=External Links=		=External Links=

Richardpruen at 13:28, 27 December 2020

2020-12-27T13:28:23Z

← Older revision		Revision as of 14:28, 27 December 2020
Line 2:		Line 2:
	__TOC__		__TOC__

	Chronic obstructive pulmonary disease, or COPD, describes a group of lung conditions that make it difficult to empty air out of the lungs because the airways have become narrowed. On this page:		Chronic obstructive pulmonary disease, or COPD, describes a group of lung conditions that make it difficult to empty air out of the lungs because the airways have become narrowed.

			See also [[Asthma]]

			On this page:

	===What does COPD stand for?===		===What does COPD stand for?===

Richardpruen: tidy up

2020-12-17T17:10:27Z

tidy up

← Older revision		Revision as of 18:10, 17 December 2020
Line 10:		Line 10:
	'''Disease'''= it’s a medical condition Two of these lung conditions are long-term (or chronic) bronchitis and [https://www.blf.org.uk/support-for-you/copd/emphysema emphysema], which can often occur together.<br>		'''Disease'''= it’s a medical condition Two of these lung conditions are long-term (or chronic) bronchitis and [https://www.blf.org.uk/support-for-you/copd/emphysema emphysema], which can often occur together.<br>

	* '''Bronchitis'''means the airways are inflamed and narrowed. People with bronchitis often produce sputum, or phlegm.		* '''Bronchitis''' means the airways are inflamed and narrowed. People with bronchitis often produce sputum, or phlegm.
	* '''Emphysema'''affects the tiny air sacs at the end of the airways in your lungs, where oxygen is taken up into your bloodstream. They break down and the lungs become baggy and full of bigger holes which trap air.		* '''Emphysema''' affects the tiny air sacs at the end of the airways in your lungs, where oxygen is taken up into your bloodstream. They break down and the lungs become baggy and full of bigger holes which trap air.
	These conditions narrow the airways. This makes it harder to move air in and out as you breathe, and your lungs are less able to take in oxygen and get rid of carbon dioxide.		These conditions narrow the airways. This makes it harder to move air in and out as you breathe, and your lungs are less able to take in oxygen and get rid of carbon dioxide.

Richardpruen at 17:09, 17 December 2020

2020-12-17T17:09:58Z

← Older revision		Revision as of 18:09, 17 December 2020
Line 5:		Line 5:

	===What does COPD stand for?===		===What does COPD stand for?===
	'''Chronic'''= it’s a long-term condition and does not go away		'''Chronic'''= it’s a long-term condition and does not go away<br>
	'''Obstructive'''= your airways are narrowed, so it’s harder to breathe out quickly and air gets trapped in your chest		'''Obstructive'''= your airways are narrowed, so it’s harder to breathe out quickly and air gets trapped in your chest <br>
	'''Pulmonary'''= it affects your lungs		'''Pulmonary'''= it affects your lungs<br>
	'''Disease'''= it’s a medical condition Two of these lung conditions are long-term (or chronic) bronchitis and [https://www.blf.org.uk/support-for-you/copd/emphysema emphysema], which can often occur together.		'''Disease'''= it’s a medical condition Two of these lung conditions are long-term (or chronic) bronchitis and [https://www.blf.org.uk/support-for-you/copd/emphysema emphysema], which can often occur together.<br>

	* '''Bronchitis'''means the airways are inflamed and narrowed. People with bronchitis often produce sputum, or phlegm.		* '''Bronchitis'''means the airways are inflamed and narrowed. People with bronchitis often produce sputum, or phlegm.
	* '''Emphysema'''affects the tiny air sacs at the end of the airways in your lungs, where oxygen is taken up into your bloodstream. They break down and the lungs become baggy and full of bigger holes which trap air.		* '''Emphysema'''affects the tiny air sacs at the end of the airways in your lungs, where oxygen is taken up into your bloodstream. They break down and the lungs become baggy and full of bigger holes which trap air.

Richardpruen at 17:01, 17 December 2020

2020-12-17T17:01:34Z

← Older revision		Revision as of 18:01, 17 December 2020
Line 2:		Line 2:
	__TOC__		__TOC__

	Chronic obstructive pulmonary disease, or COPD, describes a group of lung conditions that make it difficult to empty air out of the lungs because the airways have become narrowed.On this page:		Chronic obstructive pulmonary disease, or COPD, describes a group of lung conditions that make it difficult to empty air out of the lungs because the airways have become narrowed. On this page:

	===What does COPD stand for?===		===What does COPD stand for?===

Richardpruen at 17:00, 17 December 2020

2020-12-17T17:00:39Z

← Older revision		Revision as of 18:00, 17 December 2020
Line 3:		Line 3:

	Chronic obstructive pulmonary disease, or COPD, describes a group of lung conditions that make it difficult to empty air out of the lungs because the airways have become narrowed.On this page:		Chronic obstructive pulmonary disease, or COPD, describes a group of lung conditions that make it difficult to empty air out of the lungs because the airways have become narrowed.On this page:
	* [https://www.blf.org.uk/support-for-you/copd/what-is-copd#what What is COPD?]
	* [https://www.blf.org.uk/support-for-you/copd/what-is-copd#causes What causes COPD?]
	* [https://www.blf.org.uk/support-for-you/copd/what-is-copd#symptoms What are the symptoms of COPD?]

	===What does COPD stand for?===		===What does COPD stand for?===

Richardpruen at 16:58, 17 December 2020

2020-12-17T16:58:53Z

← Older revision		Revision as of 17:58, 17 December 2020
Line 57:		Line 57:
	Rise and Vape Podcast double issue on Asthma and COPD		Rise and Vape Podcast double issue on Asthma and COPD

	{{#ev:soundcloud\|https://soundcloud.com/riseandvape/asthmacopd-vaping-part-1-asthma}}		Episode 1 Asthma {{#ev:soundcloud\|https://soundcloud.com/riseandvape/asthmacopd-vaping-part-1-asthma}}


	{{#ev:soundcloud\|https://soundcloud.com/riseandvape/asthmacopd-vaping-part-2-copd}}		Episode 2 COPD {{#ev:soundcloud\|https://soundcloud.com/riseandvape/asthmacopd-vaping-part-2-copd}}